Mar 132017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, WA – Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that Robert W. Azelby has been appointed to the Company's Board of Directors.… => Read more

Cascadian Therapeutics appoints Robert Azelby to its Board of Directors

From:: Cascadian Therapeutics appoints Robert Azelby to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: